Actualización en la prescripción de fluoroquinolonas

J. L. Carrillo-Alduenda; F. J. Flores-Murrieta; A. N. Rodríguez-Alcocer

doi:10.24245/mim.v34i1.1429

Actualización en la prescripción de fluoroquinolonas

J. L. Carrillo-Alduenda, F. J. Flores-Murrieta, A. N. Rodríguez-Alcocer

Escuela Superior de Medicina (ESM)

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

3 Citas (Scopus)

Resumen

Quinolones or fluoroquinolones are a group of commonly prescribed and broad-spectrum antibiotics drugs that act by inhibiting the enzymes responsible for the bacterial DNA replication, transcription, repair and recombination. The aim of this article is to present a systematic review of the three most representative fluoroquinolones in our country (ciprofloxacin, levofloxacin and moxifloxacin) in their three authorized indications: lower respiratory tract infections, urinary tract infections, skin and soft tissues infections.

Título traducido de la contribución	Update on the prescription of fluoroquinolones
Idioma original	Español
Páginas (desde-hasta)	89-105
Número de páginas	17
Publicación	Medicina Interna de Mexico
Volumen	34
N.º	1
DOI	https://doi.org/10.24245/mim.v34i1.1429
Estado	Publicada - 1 ene. 2018

Palabras clave

Ciprofloxacin
Fluoroquinolones
Levofloxacin
Quinolones

Acceder al documento

10.24245/mim.v34i1.1429

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{0701e5870d6b40a7aec9e027e5bdf278,

title = "Actualizaci{\'o}n en la prescripci{\'o}n de fluoroquinolonas",

abstract = "Quinolones or fluoroquinolones are a group of commonly prescribed and broad-spectrum antibiotics drugs that act by inhibiting the enzymes responsible for the bacterial DNA replication, transcription, repair and recombination. The aim of this article is to present a systematic review of the three most representative fluoroquinolones in our country (ciprofloxacin, levofloxacin and moxifloxacin) in their three authorized indications: lower respiratory tract infections, urinary tract infections, skin and soft tissues infections.",

keywords = "Ciprofloxacin, Fluoroquinolones, Levofloxacin, Quinolones",

author = "Carrillo-Alduenda, {J. L.} and Flores-Murrieta, {F. J.} and Rodr{\'i}guez-Alcocer, {A. N.}",

year = "2018",

month = jan,

day = "1",

doi = "10.24245/mim.v34i1.1429",

language = "Espa{\~n}ol",

volume = "34",

pages = "89--105",

journal = "Medicina Interna de Mexico",

issn = "0186-4866",

number = "1",

}

TY - JOUR

T1 - Actualización en la prescripción de fluoroquinolonas

AU - Carrillo-Alduenda, J. L.

AU - Flores-Murrieta, F. J.

AU - Rodríguez-Alcocer, A. N.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Quinolones or fluoroquinolones are a group of commonly prescribed and broad-spectrum antibiotics drugs that act by inhibiting the enzymes responsible for the bacterial DNA replication, transcription, repair and recombination. The aim of this article is to present a systematic review of the three most representative fluoroquinolones in our country (ciprofloxacin, levofloxacin and moxifloxacin) in their three authorized indications: lower respiratory tract infections, urinary tract infections, skin and soft tissues infections.

AB - Quinolones or fluoroquinolones are a group of commonly prescribed and broad-spectrum antibiotics drugs that act by inhibiting the enzymes responsible for the bacterial DNA replication, transcription, repair and recombination. The aim of this article is to present a systematic review of the three most representative fluoroquinolones in our country (ciprofloxacin, levofloxacin and moxifloxacin) in their three authorized indications: lower respiratory tract infections, urinary tract infections, skin and soft tissues infections.

KW - Ciprofloxacin

KW - Fluoroquinolones

KW - Levofloxacin

KW - Quinolones

UR - http://www.scopus.com/inward/record.url?scp=85043486401&partnerID=8YFLogxK

U2 - 10.24245/mim.v34i1.1429

DO - 10.24245/mim.v34i1.1429

M3 - Artículo

SN - 0186-4866

VL - 34

SP - 89

EP - 105

JO - Medicina Interna de Mexico

JF - Medicina Interna de Mexico

IS - 1

ER -

Actualización en la prescripción de fluoroquinolonas

Resumen

Palabras clave

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto